Results 101 to 110 of about 11,489 (193)

Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome-Coronavirus Spike Protein. [PDF]

J Infect Dis, 2023
Raadsen MP, Dahlke C, Fathi A, Lamers MM, van den Doel P, Zaeck LM, van Royen ME, de Bruin E, Sikkema R, Koopmans M, van Gorp ECM, Sutter G, de Vries RD, Addo MM, Haagmans BL.   +14 more
europepmc   +1 more source

Development of vaccines for HIV-1: relevance of subtype-specific cellular immunity [PDF]

, 2010
Han pasado casi 30 años de la detección de los primeros casos de infección con HIV-1 y aún no se ha conseguido desarrollar una vacuna efectiva y segura.
Falivene, Juliana, Gherardi, Maria Magdalena, Pascutti, María Fernanda, Rodríguez, Ana María, Turk, Gabriela Julia Ana   +4 more
core  

OX40L-expressing recombinant modified vaccinia virus Ankara induces potent antitumor immunity via reprogramming Tregs. [PDF]

J Exp Med, 2023
Yang N, Wang Y, Liu S, Tariq SB, Luna JM, Mazo G, Tan A, Zhang T, Wang J, Yan W, Choi J, Rossi A, Xiang JZ, Rice CM, Merghoub T, Wolchok JD, Deng L.   +16 more
europepmc   +1 more source

Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant. [PDF]

NPJ Vaccines, 2022
Yang N, Garcia A, Meyer C, Tuschl T, Merghoub T, Wolchok JD, Deng L.   +6 more
europepmc   +1 more source

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans [PDF]

, 2003
Samuel McConkey, William H. H. Reece, Vasee Moorthy, Daniel Webster, Susanna Dunachie, Geoff Butcher, Jenni M. Vuola, Tom Blanchard, Philip Gothard, Kate E. Watkins, Carolyn M. Hannan, S. Everaere, Karen Brown, Kent E. Kester, James F. Cummings, Jackie Williams, D. Gray Heppner, Ansar A. Pathan, Katie L. Flanagan, Nirmalan Arulanantham, Mark Roberts, Michael J. Roy, Geoffrey L. Smith, J Schneider, Tim Peto, Robert E. Sinden, Sarah C. Gilbert, Adrian V. S. Hill   +27 more
openalex   +1 more source

Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. [PDF]

Vaccines (Basel), 2023
Wilken L, Stelz S, Agac A, Sutter G, Prajeeth CK, Rimmelzwaan GF.   +5 more
europepmc   +1 more source

Enhanced Immunogenicity and Protective Efficacy Against Mycobacterium tuberculosis of Bacille Calmette-Guérin Vaccine Using Mucosal Administration and Boosting with a Recombinant Modified Vaccinia Virus Ankara [PDF]

, 2003
Nilu Goonetilleke, Helen McShane, Carolyn M. Hannan, Richard Anderson, Roger H. Brookes, Adrian V. S. Hill   +5 more
openalex   +1 more source

A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection. [PDF]

Front Immunol, 2023
Kubinski M, Beicht J, Zdora I, Biermann J, Puff C, Gerlach T, Tscherne A, Baumgärtner W, Osterhaus ADME, Sutter G, Prajeeth CK, Rimmelzwaan GF.   +11 more
europepmc   +1 more source

Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein. [PDF]

Vaccines (Basel), 2022
Kupke A, Volz A, Dietzel E, Freudenstein A, Schmidt J, Shams-Eldin H, Jany S, Sauerhering L, Krähling V, Gellhorn Serra M, Herden C, Eickmann M, Becker S, Sutter G.   +13 more
europepmc   +1 more source

Recombinant Modified Vaccinia Virus Ankara Expressing a Soluble Form of Glycoprotein B Causes Durable Immunity and Neutralizing Antibodies against Multiple Strains of Human Cytomegalovirus [PDF]

, 2004
Zhongde Wang, Corinna La Rosa, Rebecca Maas, Heang Ly, John C. Brewer, Shahram Mekhoubad, Pirouz Daftarian, Jeff Longmate, William J. Britt, Don J. Diamond   +9 more
openalex   +1 more source